|
Turmeric for Patients With Basal Joint Arthritis
RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2017-08-09
Est. completion2027-12
Eligibility
Age40 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT03017118
Summary
The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.
Eligibility
Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria: * 40 years of age or older * English fluency and literacy * Seeking care for basal joint pain * Tender over basal joint * Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction) * Radiographic evidence of Eaton stage 1 and 2 only Exclusion Criteria: * Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment * Inability or unwillingness to participate in a trial study * Rheumatoid Arthritis or other inflammatory disorder diagnoses * Post-traumatic osteoarthritis * Patients on Coumadin/Steroids/NSAIDs/Tylenol * Diabetes Mellitus * Pregnant or lactating women * Basal joint arthritis of Eaton stage 3 * Patients seeking other treatment for their basal joint arthritis (splint, corticosteroid injection, surgery)
Conditions2
ArthritisThumb Osteoarthritis
Locations1 site
Massachusetts General Hospital
Boston, Massachusetts, 02114
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2017-08-09
Est. completion2027-12
Eligibility
Age40 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT03017118